Pinnacle Wealth Planning Services, Inc. Pfizer Inc Transaction History

Pinnacle Wealth Planning Services, Inc.

$748 Million
Q2 2025

A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 24,875 shares of PFE stock, worth $680,828. This represents 0.08% of its overall portfolio holdings.

Number of Shares

24,875

Previous 21,189 17.4%

Holding current value

$680,828

Previous $536,000 12.31%

% of portfolio

0.08%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$21.59 - $24.84 $79,580 - $91,560	3,686 Added 17.4%	24,875 $602,000
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $162,264 - $176,019	6,488 Added 44.13%	21,189 $536,000
Q4 2024 Feb 06, 2025	SELL	$24.8 - $30.19 $375,273 - $456,835	-15,132 Reduced 50.72%	14,701 $390,000
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $11,578 - $13,121	418 Added 1.42%	29,833 $863,000
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $27,508 - $32,234	1,089 Added 3.84%	29,415 $823,000
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $168,958 - $194,017	-6,526 Reduced 18.72%	28,326 $786,000
Q4 2023 Feb 07, 2024	BUY	$26.13 - $33.94 $305,015 - $396,181	11,673 Added 50.36%	34,852 $1 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $115,684 - $135,223	-3,605 Reduced 13.46%	23,179 $768,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $456,737 - $528,434	-12,645 Reduced 32.07%	26,784 $982,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $85,712 - $111,585	2,176 Added 5.84%	39,429 $1.61 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $392,241 - $512,027	9,395 Added 33.72%	37,253 $1.91 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $264,222 - $322,549	-6,038 Reduced 17.81%	27,858 $1.22 Million
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $267,826 - $317,558	5,756 Added 20.45%	33,896 $1.78 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $161,040 - $199,548	-3,520 Reduced 11.12%	28,140 $1.46 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $77,392 - $114,721	1,873 Added 6.29%	31,660 $1.87 Million
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $72,220 - $92,772	1,840 Added 6.58%	29,787 $1.28 Million
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $149,206 - $169,025	4,155 Added 17.46%	27,947 $1.1 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $39,283 - $44,304	-1,173 Reduced 4.7%	23,792 $862,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $34,909 - $44,390	-1,043 Reduced 4.01%	24,965 $919,000
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $173,482 - $203,534	5,464 Added 26.6%	26,008 $955,000
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $13,704 - $16,625	455 Added 2.26%	20,544 $672,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $143,204 - $204,608	-5,298 Reduced 20.87%	20,089 $654,000
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $294,337 - $334,035	8,941 Added 54.37%	25,387 $994,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $3,606 - $4,676	-111 Reduced 0.67%	16,446 $590,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $32,764 - $36,786	886 Added 5.65%	16,557 $718,000
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $143,437 - $157,590	-3,825 Reduced 19.62%	15,671 $666,000
Q4 2018 Mar 01, 2019	SELL	$38.47 - $43.86 $75,708 - $86,316	-1,968 Reduced 9.17%	19,496 $851,000
Q3 2018 Feb 28, 2019	SELL	$34.47 - $41.81 $12,788 - $15,511	-371 Reduced 1.7%	21,464 $945,000
Q2 2018 Feb 28, 2019	SELL	$32.98 - $35.16 $13,060 - $13,923	-396 Reduced 1.78%	21,835 $792,000
Q1 2018 Feb 28, 2019	BUY	$31.91 - $37.02 $538,927 - $625,230	16,889 Added 316.15%	22,231 $789,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $177,674 - $188,519	5,342	5,342 $194,000

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.

Account

Pinnacle Wealth Planning Services, Inc. Pfizer Inc Transaction History